Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06116266 · ClinicalTrials.gov registry record · NA
Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care)
A NA study of Substance Use, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 8
- Study locations
NCT06116266: Recruiting NA study of Substance Use, sponsored by NYU Langone Health.
NCT06116266 is a NA study of Substance Use that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 350 participants, below the 1,256-participant average among 88 other Substance Use trials with a reported enrollment target (72% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06116266, a NA study of Substance Use, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this trial is to test the efficacy of a collaborative care intervention to address opioid- and/or stimulant-involved polysubstance use in adult primary care patients with moderate to severe substance use disorders (SUD). The primary aims are to reduce days of opioid use (illicit or nonmedical opioid use), days of illicit stimulant use (cocaine, methamphetamine), and days of heavy alcohol use.
Primary Outcome
Days of opioid use are defined as days with any use of heroin or synthetic opioids, or nonmedical use of prescription opioids. Nonmedical use includes using prescription opioids more than prescribed (e.g., taking two tablets when the prescription indicates a dose of one tablet) or taking pharmaceutical opioids that were not prescribed to the individual taking them. Days of stimulant use are defined as days with any use of cocaine or methamphetamine. Days of alcohol heavy drinking are defined as
Conditions Studied
Interventions
- OTHER Education and support for primary care providers (PCPS)
- OTHER Nurse Care Manager (NCM) visits
- OTHER Addiction specialist consultant
- OTHER Health coaching sessions
- OTHER Patient educational materials
Study Locations (8)
New York
- NYU Langone Health - New York
- The Institute for Family Health - New York
California
- Harbor-UCLA Medical Center - Torrance
Oregon
- Winding Waters Medical Clinic - Enterprise
Pennsylvania
- Union Community Care - Lancaster
Texas
- Harris Health - Houston
Washington
- Sea Mar Community Health Centers - Bellingham
Wisconsin
- Wisconsin Research & Education Network - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2025-01-31 |
| Est. Completion | 2027-02 |
| Phase | NA |
What NCT06116266 shows while recruiting
NCT06116266 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 1,256-participant average among 88 other Substance Use trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 5 interventions - of which Education and support for primary care providers (PCPS) is the first listed.
NCT06116266 lists 8 locations in 7 states (New York, California, Oregon).
Frequently Asked Questions
What is clinical trial NCT06116266 about?
NCT06116266 is a clinical study titled "Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care)". The purpose of this trial is to test the efficacy of a collaborative care intervention to address opioid- and/or stimulant-involved polysubstance use in adult primary care patients with moderate to severe substance use disorders (SUD). The primary aims are to reduce days of opioid use (illicit or no...
What is the current status of trial NCT06116266?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2025-01-31. Estimated completion is 2027-02.
What conditions does trial NCT06116266 study?
This clinical trial studies the following conditions: Substance Use.
What interventions are being tested in trial NCT06116266?
The interventions under investigation include: Education and support for primary care providers (PCPS) (OTHER), Nurse Care Manager (NCM) visits (OTHER), Addiction specialist consultant (OTHER), Health coaching sessions (OTHER), Patient educational materials (OTHER).
Who is sponsoring clinical trial NCT06116266?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06116266 being conducted?
This trial has 8 study locations across California, New York, Oregon, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06116266's enrollment target sits among peer trials
350 28th of 88 higher than 60 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI